Exagen, Inc. (XGN)
7.16
+0.02
(+0.28%)
USD |
NASDAQ |
Dec 11, 15:18
Exagen Market Cap: 162.27M for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| FONAR Corp. | 93.25M |
| XWELL, Inc. | 4.608M |
| ProPhase Labs, Inc. | 6.641M |
| Veracyte, Inc. | 3.348B |
| Insight Molecular Diagnostics, Inc. | 149.34M |
Market Cap Related Metrics
| PS Ratio | 2.280 |
| Price to Book Value | 8.946 |
| Price | 7.16 |
| Earnings Yield | -12.93% |